Literature DB >> 8622968

Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus.

K J Kotkow1, S H Orkin.   

Abstract

High-level globin expression in erythroid precursor cells depends on the integrity of NF-E2 recognition sites, transcription factor AP-1-like protein-binding motifs, located in the upstream regulatory regions of the alpha- and beta-globin loci. The NF-E2 transcription factor, which recognizes these sites, is a heterodimer consisting of (i) p45 NF-E2 (the larger subunit), a hematopoietic-restricted basic leucine zipper protein, and (ii) a widely expressed basic leucine zipper factor, p18 NF-E2, the smaller subunit. p18 NF-E2 protein shares extensive homology with the maf protooncogene family. To determine an in vivo role for p18 NF-E2 protein we disrupted the p18 NF-E2-encoding gene by homologous recombination in murine embryonic stem cells and generated p18 NF-E2-/- mice. These mice are indistinguishable from littermates throughout all phases of development and remain healthy in adulthood. Despite the absence of expressed p18 NF-E2, DNA-binding activity with the properties of the NF-E2 heterodimer is present in fetal liver erythroid cells of p18 NF-E2-/- mice. We speculate that another member of the maf basic leucine zipper family substitutes for the p18 subunit in a complex with p45 NF-E2. Thus, p18 NF-E2 per se appears to be dispensable in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622968      PMCID: PMC39641          DOI: 10.1073/pnas.93.8.3514

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Meticulous AP-1 factors.

Authors:  J D Engel
Journal:  Nature       Date:  1994-02-10       Impact factor: 49.962

2.  The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor.

Authors:  S P Cordes; G S Barsh
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

3.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.

Authors:  E Li; T H Bestor; R Jaenisch
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

4.  Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.

Authors:  J J Caterina; D Donze; C W Sun; D J Ciavatta; T M Townes
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

5.  Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins.

Authors:  K Igarashi; K Kataoka; K Itoh; N Hayashi; M Nishizawa; M Yamamoto
Journal:  Nature       Date:  1994-02-10       Impact factor: 49.962

6.  Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein.

Authors:  N C Andrews; H Erdjument-Bromage; M B Davidson; P Tempst; S H Orkin
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

7.  Rescue of GATA-1-deficient embryonic stem cells by heterologous GATA-binding proteins.

Authors:  G A Blobel; M C Simon; S H Orkin
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene.

Authors:  N C Andrews; K J Kotkow; P A Ney; H Erdjument-Bromage; P Tempst; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun.

Authors:  K Kataoka; M Noda; M Nishizawa
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression.

Authors:  S J Lu; S Rowan; M R Bani; Y Ben-David
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more
  16 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins.

Authors:  Hiromi Yamazaki; Fumiki Katsuoka; Hozumi Motohashi; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

3.  Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1.

Authors:  O Johnsen; N Skammelsrud; L Luna; M Nishizawa; H Prydz; A B Kolstø
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

Review 4.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 5.  The world according to Maf.

Authors:  H Motohashi; J A Shavit; K Igarashi; M Yamamoto; J D Engel
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

6.  Multiple regions of p45 NF-E2 are required for beta-globin gene expression in erythroid cells.

Authors:  T L Bean; P A Ney
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

7.  The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth.

Authors:  Béata Töröcsik; James M Angelastro; Lloyd A Greene
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

8.  One enhancer mediates mafK transcriptional activation in both hematopoietic and cardiac muscle cells.

Authors:  F Katsuoka; H Motohashi; K Onodera; N Suwabe; J D Engel; M Yamamoto
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

9.  Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response.

Authors:  Fumiki Katsuoka; Hozumi Motohashi; Yuna Tamagawa; Shigeo Kure; Kazuhiko Igarashi; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice.

Authors:  K Onodera; J A Shavit; H Motohashi; M Yamamoto; J D Engel
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.